REDHILL BIOPHARMA LTD's ticker is and the CUSIP is 757468953. A total of 1 filers reported holding REDHILL BIOPHARMA LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 4,500 | +2.3% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 4,400 | -2.2% | 0.00% | – |
| Q2 2022 | $3,000 | -86.4% | 4,500 | -48.9% | 0.00% | – |
| Q1 2022 | $22,000 | -82.9% | 8,800 | -82.5% | 0.00% | – |
| Q4 2021 | $129,000 | +21.7% | 50,300 | +235.3% | 0.00% | – |
| Q3 2021 | $106,000 | +2.9% | 15,000 | 0.0% | 0.00% | – |
| Q2 2021 | $103,000 | -11.2% | 15,000 | +9334.0% | 0.00% | – |
| Q1 2021 | $116,000 | – | 159 | -18.0% | 0.00% | – |
| Q4 2020 | $0 | – | 194 | +102.1% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 96 | +540.0% | 0.00% | – |
| Q2 2020 | $10,000 | -41.2% | 15 | -61.5% | 0.00% | – |
| Q1 2020 | $17,000 | -51.4% | 39 | -33.9% | 0.00% | – |
| Q4 2019 | $35,000 | -27.1% | 59 | -14.5% | 0.00% | – |
| Q3 2019 | $48,000 | +242.9% | 69 | +283.3% | 0.00% | – |
| Q1 2019 | $14,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |